Suppression of calcium release from inositol 1,4,5-trisphosphate-sensitive stores mediates the anti-apoptotic
Simonetta Camandola1, Roy G Cutler, Devin S Gary
1Laboratory of Neurosciences, National Institute on Aging/NIH, Gerontology Research Center, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA. camandolasi@grc.nia.nih.gov
Abstract:
The activation of the transcription factor nuclear factor-kappaB (NF-kappaB) by growth factors, cytokines, and cellular stress can prevent apoptosis, but the underlying mechanism is unknown. Here we provide evidence for an action of NF-kappaB on calcium signaling that accounts for its anti-apoptotic function. Embryonic fibroblasts lacking the transactivating subunit of NF-kappaB RelA (p65) exhibit enhanced inositol 1,4,5-trisphosphate (IP(3)) receptor-mediated calcium release and increased sensitivity to apoptosis, which are restored upon re-expression of RelA. The size of the endoplasmic reticulum (ER) calcium pool and the number of IP(3) receptors per cell are decreased in response to stimuli that activate NF-kappaB and are increased when NF-kappaB activity is suppressed. The selective antagonism of IP(3) receptors blocks apoptosis in RelA-deficient cells, whereas activation of NF-kappaB in normal cells leads to decreased levels of the type 1 IP(3) receptor and decreased calcium release. Overexpression of Bcl-2 normalizes ER calcium homeostasis and prevents calcium-mediated apoptosis in RelA-deficient cells. These findings establish an ER calcium channel as a pivotal target for NF-kappaB-mediated cell survival signaling.
Insights
Nuclear factor-kappaB (NF-kappaB) prevents cell death by regulating calcium signaling. NF-kappaB activation decreases calcium release via inositol trisphosphate (IP3) receptors, promoting cell survival.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Nuclear factor-kappaB (NF-kappaB) activation by various stimuli confers resistance to apoptosis.
- The precise molecular mechanisms underlying NF-kappaB's anti-apoptotic function remain largely unknown.
- Calcium signaling is implicated in cellular stress responses and apoptosis.
Purpose of the Study:
- To elucidate the mechanism by which NF-kappaB activation prevents apoptosis.
- To investigate the role of calcium signaling in NF-kappaB-mediated cell survival.
- To identify specific targets of NF-kappaB involved in regulating calcium homeostasis.
Main Methods:
- Utilized embryonic fibroblasts deficient in the RelA (p65) subunit of NF-kappaB.
- Measured inositol 1,4,5-trisphosphate (IP(3)) receptor-mediated calcium release from the endoplasmic reticulum (ER).
- Assessed apoptosis sensitivity, ER calcium pool size, and IP(3) receptor levels under varying NF-kappaB activity conditions.
- Investigated the effects of IP(3) receptor antagonism and Bcl-2 overexpression.
Main Results:
- RelA-deficient cells showed increased IP(3) receptor-mediated calcium release and apoptosis sensitivity.
- NF-kappaB activation decreased ER calcium pool size and IP(3) receptor levels.
- Blocking IP(3) receptors prevented apoptosis in RelA-deficient cells.
- Overexpression of Bcl-2 restored ER calcium homeostasis and prevented apoptosis.
Conclusions:
- NF-kappaB exerts its anti-apoptotic function by modulating calcium signaling pathways.
- The endoplasmic reticulum calcium channel, specifically the type 1 IP(3) receptor, is a key target of NF-kappaB.
- NF-kappaB-mediated regulation of ER calcium homeostasis is crucial for cell survival.
Related Concept Videos
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Apoptosis

